Home Resources Practical Tips for Making and Working with dbDNA™

Practical Tips for Making and Working with dbDNA™

dbDNA™ (doggybone™ DNA) enables a powerful, cell-free route to high quality linear DNA. Its advantages are best realized when construct design, enzymatic steps, and cleanup strategies are carefully aligned with the intended application. By applying the practical tips outlined here, users can streamline their workflows, improve yields, and confidently deploy dbDNA across a wide range of research and production settings. 

 

Designing Your dbDNA Construct for Success

Choosing the Right Cloning Strategy

The EnClose™ Cell-free dbDNA™ Synthesis Kit includes a dbDNA Vector designed as a versatile backbone compatible with most dbDNA applications. The dbDNA Vector supports three primary cloning strategies—α (alpha), β (beta), and γ (gamma)—which differ in the presence and length of stuffer sequences flanking the sequence of interest (SOI). Selecting the correct strategy is one of the most important decisions in a dbDNA workflow:

  • α strategy (no stuffers) is best for non-viral and IVT applications where compact size is preferred.
  • β strategy (200 bp stuffers) is recommended for AAV payloads containing inverted terminal repeats (ITRs) and for certain lentiviral applications.
  • γ strategy (200 bp + 806 bp stuffers) is optimal for more complex lentiviral payloads, including those containing LTRs, gag, pol, or rev sequences.  

Tip: For transient protein expression, especially in non-viral contexts, additional stuffer sequences are usually unnecessary. In these cases, minimizing construct size by using the α cloning strategy (no stuffers) can improve performance and simplify downstream interpretation. More information on cloning your SOI into the dbDNA Vector can be found here.

 

Stuffer Sequences: When and Why They Matter

While stuffers may seem like inert DNA, they serve important structural and functional roles in some applications:

  • They increase the physical distance between structured elements (such as ITRs) and the protelomerase (telRL) cleavage sites.
  • They provide reliable primer binding regions for sequencing.
  • They can improve functional output in lentiviral workflows by stabilizing vector architecture. 

Tip: Include stuffers when working with highly structured elements or viral genomes, and omit them for simpler constructs, unless performance data suggest otherwise.

 

Preparing High Quality Circular Input DNA

Template Quality Is Critical

The dbDNA amplification workflow begins with a circular DNA template. This can be a plasmid cloned in E. coli or an assembled dbDNA Vector construct. We recommend using the dbDNA Vector included in the kit as a positive control for initial dbDNA assembly and when troubleshooting.

Tips: Regardless of origin, the template must:

  • Contain the correct protelomerase (telRL) recognition sites flanking the SOI, or SOI + stuffer sequence.
  • Be free of contaminating restriction sites (within the SOI) that are used later for processing. 
  • Be of sufficient purity to support robust rolling circle amplification (RCA). 

 

Primer Considerations for RCA

Due to the strong exonuclease activity of phi29-XT DNA polymerase, it is critical that the 3′ ends of the primers are protected by including 2-3 phosphorothioate bonds. The EnClose™ Cell-free dbDNA™ Synthesis Kit includes exonuclease-resistant specific primers designed to anneal within the kanamycin resistance cassette of the dbDNA Vector. These primers are optimized to reduce nonspecific amplification and to withstand the strong proofreading activity of phi29-XT DNA Polymerase.

Tips:  

  • If custom primers are used:
    • Protect the 3′ end with at least two phosphorothioate bonds.
    • Keep primer length moderate (typically 13–16 bases).
    • Avoid G- or C-rich sequences near the 3′ end to reduce mis-priming.
  • Exonuclease-resistant random primers can also be used but may affect the final yield and purity of dbDNA generated.
  • Some custom primers are less efficient than the specific primers included in the kit. If the yield with specific primers is too low, the RCA reaction time may need to be increased to ensure adequate yield.

 

Rolling Circle Amplification Maximizes Yield and Specificity

Working with Viscous RCA Products

A successful RCA reaction generates very large amounts of DNA, often resulting in a viscous or even cloudy mixture. This is expected and generally indicates strong amplification rather than a problem.

Tips:

  • Mix gently but thoroughly; wide bore tips can help.
  • Avoid over-incubation—extending RCA beyond ~3 hours rarely improves yield and may increase nonspecific products.
  • If a higher yield is needed, the dbDNA reaction volumes can be scaled up linearly to generate a proportionally higher yield. 

 

Temperature Matters

Rolling circle amplification can be accomplished using either phi29 wild-type or phi29-XT DNA polymerase. The EnClose™ Cell-free dbDNA™ Synthesis Kit employs phi29-XT DNA Polymerase since it is more efficient than the wild-type phi29, making it ideal when the input DNA amount is extremely low. This allows the use of lower amounts of input plasmid DNA while still achieving efficient amplification, which in turn helps minimize the introduction of bacterial host cell proteins and endotoxin. Importantly, phi29-XT DNA Polymerase is optimized for higher temperatures than wild type phi29. Running RCA below 37°C when using phi29-XT DNA Polymerase can significantly reduce performance and is not recommended.

Tip: Maintain the recommended reaction temperature of 40°C to ensure efficient amplification and cleaner downstream processing. 

 

dbDNA Formation: Protecting Your Product

TelN Protelomerase Is Sensitive to Dilution

The conversion of RCA concatemers into closed-ended dbDNA relies on TelN Protelomerase, and is sensitive to DNA concentration. This step is optimal when TelN is directly added to the RCA reaction.

Tips:

  • Do not dilute the RCA reaction before adding TelN. If the mixture is too viscous to pipette comfortably, consider using wide-bore pipette tips.
  • Add the enzyme directly to the viscous RCA mixture and mix thoroughly.
  • Expect reduced yield if dilution occurs prior to this step. 

 

Scale Accordingly

While large-scale dbDNA production may be the ultimate goal, initial screening and proof-of-principle experiments can be conducted in volumes as low as 10 µl using the EnClose™ Cell-free dbDNA™ Synthesis Kit. This enables users to quickly and cost-effectively evaluate the advantages of dbDNA for their application before allocating additional resources to scale up. 

Tip: Save time and resources by running small scale reactions (≥10 µl) during early screening.  Consider creating a master mix of components and then aliquoting into smaller volumes.

 

Cleanup and Quality Control

Enzymatic Cleanup Strategy

Following dbDNA formation, residual linear DNA is removed through a targeted combination of restriction enzyme digestion and exonuclease treatment. The restriction enzyme specifically recognizes and cleaves the unwanted plasmid backbone—including antibiotic-resistance elements and other nonessential sequences—which is also made into a separate dbDNA product during TelN processing. This targeted cut is essential: it exposes the backbone to exonuclease activity, ensuring efficient degradation and high purity of the SOI dbDNA product.

In parallel, the T5 exonuclease performs “double duty.” In addition to degrading backbone derived fragments, its 5′→3′ activity also reduces excess primer, making it easier to remove during downstream nucleic acid cleanup.

Critical tip: Ensure the processing restriction enzyme does not cut within your SOI. If this is not feasible, an alternative restriction enzyme  should be used.

 

Purification and Yield Expectations

Final purification removes enzymes, salts, and nucleotides. Column-based high-capacity cleanup, such as the Monarch Cleanup Kits, is recommended.  Typical yields are ≥10 µg of purified dbDNA™ per 100 µl reaction.

Tips:

  • Quantify using absorbance-based (post-cleanup to remove residual NTPs) or fluorescence-based DNA assays (can be used pre- or post-cleanup, as residual NTPs should not affect readings). 
  • Visualize purity by agarose gel electrophoresis or other means (e.g., TapeStation™, LabChip™) if needed.

 

Downstream Handling and Storage

Storage and Stability

Purified dbDNA can be stored at −20°C and is stable through multiple freeze–thaw cycles when handled properly. Always use nuclease-free reagents and low-bind plasticware.

Tip: Aliquot dbDNA stocks to minimize freeze–thaw exposure for sensitive downstream applications.

 

Application Specific Considerations

Because dbDNA lacks bacterial backbone sequences and supercoiling, it can behave differently from plasmid DNA in some assays. As a result, certain applications may require less dbDNA on a mass‑to‑mass basis compared to plasmid DNA.

Tips:

Optimize input amounts empirically. Compare dbDNA performance side-by-side with plasmid controls during early experiments to determine the optimal amount of dbDNA for your application.

  • Adjust delivery or transcription conditions as needed. 
  • When using dbDNA as an in vitro transcription (IVT) template, it is essential to remove the downstream (3’) terminal hairpin using a restriction enzyme (such as BspQI-HF®) to generate a linear run-off template for transcription. 

 

Additional Resources You May Find Helpful: